M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
3 March 2010 - US-based biomedical company Inovio Biomedical Corporation (AMEX: INO) said yesterday that its affiliate VGX International Inc (SEO:011000) has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for SynCon preventive DNA vaccine (VGX-3400) targeting...
If you want to view the full text of this story, you must first purchase archive retrieval credits.